Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.
Bioceres Crop Solutions Corp. reports developments tied to crop productivity technologies for agricultural markets, including seeds, seed traits, seed treatments, biologicals, adjuvants, fertilizers, crop protection products and crop nutrition. Its recurring updates focus on operating results across crop protection, seed and integrated products, and crop nutrition, with frequent discussion of product mix, margins, working-capital discipline and conditions in Argentina.
Bioceres also announces collaboration and commercialization activity for HB4 wheat, a trait platform positioned for climate-resilient wheat production, as well as updates on capital structure matters and asset-related disputes affecting the business. Bioceres presents financial results under IFRS and regularly schedules calls around quarterly and full-year reporting periods.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) has announced a definitive agreement to acquire a 6% ownership stake in Moolec Science Ltd., a company specializing in molecular farming for animal-free food production. This strategic partnership aims to enhance Bioceres' exposure to the rapidly growing alternative protein market, which was valued at USD $14.95 billion in 2019. Moolec's innovations include the world’s first bovine protein from modified safflower grain, expected to lower production costs significantly.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) will engage in two investor conferences in March 2021. The Virtual 33rd Annual ROTH Conference will take place on March 16, featuring CFO Enrique López Lecube in virtual 1x1 meetings. The Investor Summit: Q1 Virtual Summit is scheduled for March 25 at 2:30 pm ET, with a webcast available on the company's Investor Relations website. Bioceres aims to boost agricultural carbon neutrality through innovative crop productivity technologies.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) announced the completion of a $26 million public offering of Series V corporate bonds by its subsidiary, Rizobacter Argentina S.A. The offering consisted of two tranches: Class A bonds worth $5.2 million, maturing in March 2022 at 0.98% interest, and Class B bonds totaling $20.8 million, maturing in March 2024 at 5.5% interest. Proceeds will support working capital and extend debt maturities, showcasing strong investor confidence in Bioceres' commercial progress and its commitment to advancing sustainable agriculture.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) reported its fiscal Q2 results for 2021, with revenues of $47.7 million, down from $57.0 million YoY, largely due to drought impacts. However, comparable revenues rose 8% to $167.8 million. Bioceres achieved regulatory approval for its HB4 drought-tolerant wheat, marking a significant milestone as it is the first of its kind globally. Seed inventory is anticipated to cover 60,000 to 130,000 hectares for the upcoming season. The HB4 soybean program saw an impressive 867% surge in participating growers, highlighting strong market interest.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) has entered into a multi-year research agreement with Nature Source Improved Plants to establish an HB4® Soybean breeding program in the U.S. This collaboration will utilize NSIP's advanced analytics to target drought-prone regions effectively, resulting in reduced development costs and expedited market access. The partnership aims to enhance productivity through innovative breeding technologies, addressing the significant economic impacts of droughts affecting over 69 million people and substantial agricultural losses in the U.S.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) will host a conference call on February 11, 2021, at 8:30 a.m. EST to discuss its fiscal second quarter results ended December 31, 2020. The call will feature insights from CEO Federico Trucco and CFO Enrique Lopez Lecube, followed by a Q&A session. A press release detailing the financial results will be issued before the call. Interested parties can access the call via toll-free numbers and pre-register to join.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) announced participation in the LD 500 Conference from September 1-4, 2020. CFO Enrique Lopez Lecube will present and meet selected investors, with an updated investor presentation available on the company's website during the event. Bioceres offers integrated crop productivity solutions aimed at enhancing agricultural sustainability and carbon neutrality. The company's innovative technologies include patented seeds and microbial ag-inputs, promoting environmentally friendly production practices.